Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B.

Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B.
复制标题

DOI:
10.1186/s12964-015-0104-z
复制
发表时间:
2015-06-06
期刊:
Cell communication and signaling : CCS
影响因子:
--
通讯作者:
Holien T
Holien T
中科院分区:
其他
文献类型:
--
作者:
Olsen OE;Wader KF;Hella H;Mylin AK;Turesson I;Nesthus I;Waage A;Sundan A;Holien T

文献摘要

参考文献

被引文献

相似文献

活化素是在胚胎干细胞中具有多个生物学功能的TGF-β家族的成员,以及在病理状况中,血清中的血清水平升高激活素A通过规范ALK4-ACVR2受体复合物激活转录因子Smad2和Smad3。受体,它们与某些骨形态发生蛋白(BMP)共享的特征在患有晚期疾病的骨髓瘤患者中也升高。 在这项研究中,我们研究了使用具有良好特征的BMP受体表达和反应的骨髓瘤细胞系与BMP共享的受体的影响。 -4。 BMPR2与ALK3和ALK6结合使用。 我们提出,激活素A的一种重要方法是拮抗BMP-ACVR2A/ACVR2B/ALK2信号传导。 本文的在线版本(DOI:10.1186/S12964-015-0104-Z)包含补充材料,可供授权用户使用。
Activins are members of the TGF-β family of ligands that have multiple biological functions in embryonic stem cells as well as in differentiated tissue. Serum levels of activin A were found to be elevated in pathological conditions such as cachexia, osteoporosis and cancer. Signaling by activin A through canonical ALK4-ACVR2 receptor complexes activates the transcription factors SMAD2 and SMAD3. Activin A has a strong affinity to type 2 receptors, a feature that they share with some of the bone morphogenetic proteins (BMPs). Activin A is also elevated in myeloma patients with advanced disease and is involved in myeloma bone disease. In this study we investigated effects of activin A binding to receptors that are shared with BMPs using myeloma cell lines with well-characterized BMP-receptor expression and responses. Activin A antagonized BMP-6 and BMP-9, but not BMP-2 and BMP-4. Activin A was able to counteract BMPs that signal through the type 2 receptors ACVR2A and ACVR2B in combination with ALK2, but not BMPs that signal through BMPR2 in combination with ALK3 and ALK6. We propose that one important way that activin A regulates cell behavior is by antagonizing BMP-ACVR2A/ACVR2B/ALK2 signaling. The online version of this article (doi:10.1186/s12964-015-0104-z) contains supplementary material, which is available to authorized users.
DOI: 10.1016/s1097-2765(03)00386-1
发表时间: 2003-10-01
期刊: MOLECULAR CELL
影响因子: 16
作者:
Goumans, MJ;Valdimarsdottir, G;ten Dijke, P
通讯作者: ten Dijke, P
DOI: 10.1016/j.cellsig.2013.09.002
发表时间: 2013-12-01
影响因子: 4.8
作者:
Rejon, Carlis A.;Hancock, Mark A.;Bernard, Daniel J.
通讯作者: Bernard, Daniel J.
DOI: 10.1038/bcj.2014.16
发表时间: 2014-03-21
影响因子: 12.8
作者:
Olsen, O. E.;Wader, K. F.;Misund, K.;Vatsveen, T. K.;Ro, T. B.;Mylin, A. K.;Turesson, I.;Stordal, B. F.;Moen, S. H.;Standal, T.;Waage, A.;Sundan, A.;Holien, T.
通讯作者: Holien, T.
DOI: 10.1016/0092-8674(93)90488-c
发表时间: 1993-11-19
期刊: CELL
影响因子: 64.5
作者:
ATTISANO, L;CARCAMO, J;WRANA, JL
通讯作者: WRANA, JL
DOI: 10.1074/jbc.m800850200
发表时间: 2008-07-25
影响因子: 4.8
作者:
Lavery, Karen;Swain, Pamela;Alaoui-Ismaili, Moulay Hicham
通讯作者: Alaoui-Ismaili, Moulay Hicham